NSE · BSE · Real-time
High-value corporate events — new orders, fund raises, capacity expansions, and earning calls — analysed by AI the moment they hit the exchange.
Corona Remedies reported a strong start to FY27, significantly outperforming the Indian Pharmaceutical Market across core therapy areas. The company achieved a net profit of ₹60.11 crore while successfully commercializing its advanced Europe-GMP approved hormonal manufacturing facility to drive future international expansion.
Real-time NSE & BSE event alerts, AI-summarized filings, and instant order-win signals — free for 15 days, no card required.
